[Hyperglycemia at admission and outcome in elderly patients with acute ST segment elevation myocardial infarction

Hong-jie Chi1, Da-peng Zhang, Xin-chun Yang

  • 1Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

Insights

Hyperglycemia in elderly patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) is linked to worse outcomes. Higher blood glucose levels correlate with poorer tissue perfusion, cardiac function, and increased mortality rates.

Area of Science:

  • Cardiology
  • Endocrinology
  • Geriatrics

Context:

  • Acute ST-segment elevation myocardial infarction (STEMI) is a critical cardiovascular event.
  • Primary percutaneous coronary intervention (PCI) is a standard treatment for STEMI.
  • Elderly patients represent a vulnerable population with unique physiological responses to cardiac events and interventions.

Purpose:

  • To investigate the association between admission hyperglycemia and clinical outcomes in elderly patients with STEMI who underwent primary PCI.
  • To determine if elevated blood glucose levels impact tissue perfusion, cardiac function, and mortality post-PCI.

Summary:

  • This retrospective study analyzed 284 elderly patients (≥60 years) with STEMI treated with primary PCI, categorizing them by admission blood glucose levels.
  • Results indicated that higher glucose levels (> or = 11.0 mmol/L) were associated with a higher proportion of females, longer hospital stays, increased history of hypertension, poorer TIMI myocardial perfusion grade (TMPG), higher PCI complication rates, increased Intra-aortic balloon pump (IABP) use, and elevated Killip class.
  • Most significantly, the highest glucose group exhibited substantially higher in-hospital and one-year mortality rates compared to the normoglycemic group.

Impact:

  • Admission hyperglycemia is a significant predictor of adverse outcomes in elderly STEMI patients treated with primary PCI.
  • Findings highlight the importance of glycemic control in this high-risk patient population.
  • The study suggests that hyperglycemia adversely affects myocardial reperfusion and cardiac function, contributing to increased morbidity and mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...